Physician profile
Narinder Singh Basra
NPI 1962563163
$1,586.94
in general payments reported to CMS, 2019-2025
11 companies · $51.79 in 2025
The $51.79 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $160 · 2020: $151 · 2021: $325 · 2022: $705 · 2023: $144 · 2024: $50.21 · 2025: $51.79.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $246.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $246.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $576.53 | 2021-2023 | Qulipta, Ubrelvy |
| Janssen Pharmaceuticals, INC | $489.28 | 2020-2023 | Xarelto |
| Amgen INC. | $193.88 | 2019-2025 | Evenity, Prolia |
| Pfizer INC. | $131.67 | 2021-2022 | |
| Glaxosmithkline, LLC. | $88.54 | 2019-2023 | Arexvy |
| Allergan, INC. | $31.28 | 2019-2020 | |
| Exact Sciences Corporation | $17.83 | 2025 | The Cologuard Plus Collection Kit |
| Lilly USA, LLC | $16.12 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.33 | 2021 | |
| Aimmune Therapeutics, INC. | $14.15 | 2025 | Zenpep |
| Amarin Pharma, INC. | $13.33 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Narinder Basra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.